| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | thyroid hormone binding | 6.23e-05 | 7 | 35 | 2 | GO:0070324 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 1.02e-03 | 27 | 35 | 2 | GO:0016405 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 1.34e-03 | 31 | 35 | 2 | GO:0016878 | |
| GeneOntologyMolecularFunction | TBP-class protein binding | 1.52e-03 | 33 | 35 | 2 | GO:0017025 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.91e-03 | 37 | 35 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 2.34e-03 | 41 | 35 | 2 | GO:0016877 | |
| GeneOntologyMolecularFunction | ligase activity | 3.47e-03 | 174 | 35 | 3 | GO:0016874 | |
| GeneOntologyBiologicalProcess | negative regulation of animal organ morphogenesis | 8.38e-06 | 3 | 35 | 2 | GO:0110111 | |
| GeneOntologyBiologicalProcess | negative regulation of odontogenesis | 8.38e-06 | 3 | 35 | 2 | GO:0042483 | |
| GeneOntologyBiologicalProcess | positive regulation of thyroid hormone receptor signaling pathway | 8.38e-06 | 3 | 35 | 2 | GO:0002157 | |
| GeneOntologyBiologicalProcess | female courtship behavior | 8.38e-06 | 3 | 35 | 2 | GO:0008050 | |
| GeneOntologyBiologicalProcess | courtship behavior | 5.84e-05 | 7 | 35 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | regulation of thyroid hormone receptor signaling pathway | 7.78e-05 | 8 | 35 | 2 | GO:0002155 | |
| GeneOntologyBiologicalProcess | L-histidine catabolic process | 7.78e-05 | 8 | 35 | 2 | GO:0006548 | |
| GeneOntologyBiologicalProcess | imidazole-containing compound catabolic process | 7.78e-05 | 8 | 35 | 2 | GO:0052805 | |
| GeneOntologyBiologicalProcess | thyroid hormone receptor signaling pathway | 1.00e-04 | 9 | 35 | 2 | GO:0002154 | |
| GeneOntologyBiologicalProcess | regulation of female receptivity | 1.00e-04 | 9 | 35 | 2 | GO:0045924 | |
| GeneOntologyBiologicalProcess | type I pneumocyte differentiation | 1.25e-04 | 10 | 35 | 2 | GO:0060509 | |
| GeneOntologyBiologicalProcess | L-histidine metabolic process | 1.25e-04 | 10 | 35 | 2 | GO:0006547 | |
| GeneOntologyBiologicalProcess | female mating behavior | 1.83e-04 | 12 | 35 | 2 | GO:0060180 | |
| GeneOntologyBiologicalProcess | imidazole-containing compound metabolic process | 2.51e-04 | 14 | 35 | 2 | GO:0052803 | |
| GeneOntologyBiologicalProcess | cartilage development | 7.39e-04 | 243 | 35 | 4 | GO:0051216 | |
| GeneOntologyBiologicalProcess | regulation of odontogenesis | 7.54e-04 | 24 | 35 | 2 | GO:0042481 | |
| GeneOntologyBiologicalProcess | aromatic amino acid family catabolic process | 7.54e-04 | 24 | 35 | 2 | GO:0009074 | |
| HumanPheno | Impaired sensitivity to thyroid hormone | 5.09e-06 | 2 | 12 | 2 | HP:0002930 | |
| MousePheno | increased activity of thyroid gland | 1.33e-05 | 3 | 30 | 2 | MP:0003502 | |
| MousePheno | short limbs | 8.80e-05 | 111 | 30 | 4 | MP:0000547 | |
| MousePheno | increased compact bone thickness | 9.00e-05 | 41 | 30 | 3 | MP:0004148 | |
| MousePheno | abnormal chondrocyte physiology | 9.68e-05 | 42 | 30 | 3 | MP:0009780 | |
| MousePheno | abnormal cartilage physiology | 1.04e-04 | 43 | 30 | 3 | MP:0031306 | |
| MousePheno | increased heart rate | 1.19e-04 | 120 | 30 | 4 | MP:0002626 | |
| MousePheno | abnormal cardiac muscle cell glucose uptake | 1.59e-04 | 9 | 30 | 2 | MP:0004039 | |
| MousePheno | abnormal fibrous joint morphology | 1.88e-04 | 135 | 30 | 4 | MP:0030878 | |
| MousePheno | abnormal cranium morphology | 2.35e-04 | 813 | 30 | 8 | MP:0000438 | |
| MousePheno | increased circulating triiodothyronine level | 2.42e-04 | 11 | 30 | 2 | MP:0005480 | |
| MousePheno | abnormal craniofacial bone morphology | 2.64e-04 | 827 | 30 | 8 | MP:0002116 | |
| MousePheno | abnormal head development | 3.10e-04 | 62 | 30 | 3 | MP:0012176 | |
| MousePheno | increased triiodothyronine level | 3.42e-04 | 13 | 30 | 2 | MP:0005474 | |
| MousePheno | craniofacial phenotype | 3.84e-04 | 1372 | 30 | 10 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 3.84e-04 | 1372 | 30 | 10 | MP:0000428 | |
| MousePheno | increased circulating thyroxine level | 4.59e-04 | 15 | 30 | 2 | MP:0005477 | |
| MousePheno | increased thyroxine level | 5.24e-04 | 16 | 30 | 2 | MP:0005470 | |
| MousePheno | increased circulating thyroid-stimulating hormone level | 5.94e-04 | 17 | 30 | 2 | MP:0005122 | |
| MousePheno | abnormal cartilage morphology | 6.77e-04 | 336 | 30 | 5 | MP:0000163 | |
| Domain | ThyrH_rcpt | 3.40e-05 | 5 | 35 | 2 | IPR001728 | |
| Domain | TSP1 | 2.43e-04 | 65 | 35 | 3 | SM00209 | |
| Domain | TSP1_rpt | 2.43e-04 | 65 | 35 | 3 | IPR000884 | |
| Domain | TSP1 | 2.43e-04 | 65 | 35 | 3 | PS50092 | |
| Domain | AMP-binding | 1.44e-03 | 30 | 35 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 1.44e-03 | 30 | 35 | 2 | IPR000873 | |
| Domain | SNF2_N | 1.63e-03 | 32 | 35 | 2 | PF00176 | |
| Domain | SNF2_N | 1.63e-03 | 32 | 35 | 2 | IPR000330 | |
| Domain | zf-C4 | 3.35e-03 | 46 | 35 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 3.35e-03 | 46 | 35 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 3.35e-03 | 46 | 35 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 3.35e-03 | 46 | 35 | 2 | IPR001723 | |
| Domain | ZnF_C4 | 3.35e-03 | 46 | 35 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 3.35e-03 | 46 | 35 | 2 | PS51030 | |
| Domain | - | 3.50e-03 | 47 | 35 | 2 | 1.10.565.10 | |
| Domain | HOLI | 3.65e-03 | 48 | 35 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 3.65e-03 | 48 | 35 | 2 | IPR000536 | |
| Domain | Hormone_recep | 3.65e-03 | 48 | 35 | 2 | PF00104 | |
| Domain | - | 5.10e-03 | 57 | 35 | 2 | 3.30.50.10 | |
| Domain | CUB_dom | 5.10e-03 | 57 | 35 | 2 | IPR000859 | |
| Domain | Znf_NHR/GATA | 5.28e-03 | 58 | 35 | 2 | IPR013088 | |
| Domain | TSP_1 | 6.20e-03 | 63 | 35 | 2 | PF00090 | |
| Domain | IGv | 8.69e-03 | 75 | 35 | 2 | SM00406 | |
| Pathway | REACTOME_HISTIDINE_CATABOLISM | 7.38e-05 | 7 | 27 | 2 | MM15398 | |
| Pathway | REACTOME_HISTIDINE_CATABOLISM | 9.82e-05 | 8 | 27 | 2 | M27678 | |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 1.26e-04 | 9 | 27 | 2 | M47629 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 1.92e-04 | 11 | 27 | 2 | MM1432 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 1.92e-04 | 11 | 27 | 2 | M18837 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11861164 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24673558 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 22570333 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10430610 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 37992217 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 23493375 | ||
| Pubmed | Regulation of neonatal Sertoli cell development by thyroid hormone receptor alpha1. | 9.84e-07 | 2 | 35 | 2 | 15858214 | |
| Pubmed | Audiogenic seizure susceptibility in thyroid hormone receptor beta-deficient mice. | 9.84e-07 | 2 | 35 | 2 | 11496110 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 20090848 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9927422 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 26672044 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 21622534 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 20062085 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10346821 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 17932484 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9861043 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19094093 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 38889231 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11120878 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11867729 | ||
| Pubmed | Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. | 9.84e-07 | 2 | 35 | 2 | 19131509 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 20736347 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11739587 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10362681 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11481455 | ||
| Pubmed | Impaired hair growth and wound healing in mice lacking thyroid hormone receptors. | 9.84e-07 | 2 | 35 | 2 | 25254665 | |
| Pubmed | Interference of a mutant thyroid hormone receptor alpha1 with hepatic glucose metabolism. | 9.84e-07 | 2 | 35 | 2 | 19282388 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 23300972 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 26715425 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19903799 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 20141582 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12750454 | ||
| Pubmed | Cardiac glucose utilization in mice with mutated alpha- and beta-thyroid hormone receptors. | 9.84e-07 | 2 | 35 | 2 | 15304375 | |
| Pubmed | Functionally impaired TR mutants are present in thyroid papillary cancer. | 9.84e-07 | 2 | 35 | 2 | 11889175 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 38757582 | ||
| Pubmed | Distribution of the nuclear thyroid-hormone receptor in extraocular and skeletal muscles. | 9.84e-07 | 2 | 35 | 2 | 1517709 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 28911178 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11222741 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 16051666 | ||
| Pubmed | The thyroid hormone receptors as modulators of skin proliferation and inflammation. | 9.84e-07 | 2 | 35 | 2 | 21566120 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 16781732 | ||
| Pubmed | Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo. | 9.84e-07 | 2 | 35 | 2 | 29229863 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 18844476 | ||
| Pubmed | Gaining ligand selectivity in thyroid hormone receptors via entropy. | 9.84e-07 | 2 | 35 | 2 | 19926848 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 17911173 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 26451739 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10848522 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 15780976 | ||
| Pubmed | Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice. | 9.84e-07 | 2 | 35 | 2 | 12145333 | |
| Pubmed | The two thyroid hormone receptor genes have opposite effects on estrogen-stimulated sex behaviors. | 9.84e-07 | 2 | 35 | 2 | 10769387 | |
| Pubmed | Deafness in TRbeta mutants is caused by malformation of the tectorial membrane. | 9.84e-07 | 2 | 35 | 2 | 19244534 | |
| Pubmed | Functional activation of cerebral metabolism in mice with mutated thyroid hormone nuclear receptors. | 9.84e-07 | 2 | 35 | 2 | 12933686 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24797634 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10348820 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12169435 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11726557 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 32242219 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 27732649 | ||
| Pubmed | The oligomeric state of thyroid receptor regulates hormone binding kinetics. | 9.84e-07 | 2 | 35 | 2 | 21508093 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10691312 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 1944303 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 18203951 | ||
| Pubmed | Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. | 9.84e-07 | 2 | 35 | 2 | 17327419 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19853653 | ||
| Pubmed | New Insights into the Structure and Function of the Thyroid Hormone Receptor. | 9.84e-07 | 2 | 35 | 2 | 11725045 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 20194731 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 23271024 | ||
| Pubmed | Thyroid hormone signaling controls hair follicle stem cell function. | 9.84e-07 | 2 | 35 | 2 | 25657324 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11113349 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 18287507 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24325866 | ||
| Pubmed | The thyroid hormone receptors modulate the skin response to retinoids. | 9.84e-07 | 2 | 35 | 2 | 21858227 | |
| Pubmed | Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1. | 9.84e-07 | 2 | 35 | 2 | 12356724 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9250685 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11075809 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12198244 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11731612 | ||
| Pubmed | Thyroid status during skeletal development determines adult bone structure and mineralization. | 9.84e-07 | 2 | 35 | 2 | 17488972 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9372952 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 20726222 | ||
| Pubmed | Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms. | 9.84e-07 | 2 | 35 | 2 | 20080985 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12562961 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 2879243 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 33558878 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19628582 | ||
| Pubmed | Distinct behavioral phenotypes in male mice lacking the thyroid hormone receptor α1 or β isoforms. | 9.84e-07 | 2 | 35 | 2 | 23567476 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11159823 | ||
| Pubmed | Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis. | 9.84e-07 | 2 | 35 | 2 | 19549593 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 29753845 | ||
| Pubmed | Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. | 9.84e-07 | 2 | 35 | 2 | 12591179 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 15466465 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 22322976 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10712278 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 15713690 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12776178 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 32122258 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 14630998 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19114539 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 17065405 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 24731098 | ||
| GeneFamily | Nuclear hormone receptors | 1.76e-03 | 49 | 23 | 2 | 71 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.35e-05 | 856 | 35 | 8 | M4500 | |
| Coexpression | LEIN_ASTROCYTE_MARKERS | 2.59e-05 | 43 | 35 | 3 | M1713 | |
| Coexpression | LEIN_ASTROCYTE_MARKERS | 5.16e-05 | 54 | 35 | 3 | MM715 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Tgfb1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.74e-08 | 145 | 35 | 5 | 84d50a13b48d50c16e768422908e371a55972d0e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.48e-07 | 175 | 35 | 5 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.04e-06 | 158 | 35 | 4 | 9e0589f770920f8ac41cfe5cd0a29e9e7a04a308 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.77e-06 | 162 | 35 | 4 | 2d28306c6125b31f11ea6d911a167b93a74907c5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.62e-06 | 171 | 35 | 4 | d07e2c5f7d7f12c68860d4161d76372de174f1d8 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.03e-05 | 174 | 35 | 4 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-05 | 176 | 35 | 4 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-05 | 189 | 35 | 4 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 192 | 35 | 4 | 25cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-05 | 192 | 35 | 4 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 125 | 35 | 3 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.83e-04 | 141 | 35 | 3 | ad9a25569c142fb68ded34aeba0cd9be8124ce56 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Gkn1_Pcdh19|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.95e-04 | 144 | 35 | 3 | e8caeb6485f4c8f9a3384570dc69024c2bcc9ab0 | |
| ToppCell | facs-Liver|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 158 | 35 | 3 | ea7db6bd9742153ceb6e444892a6d1df9c7fcc96 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 167 | 35 | 3 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 167 | 35 | 3 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.07e-04 | 168 | 35 | 3 | 55c9de7b3a1d6cf7b02b020ff92ab4ede8d195cc | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.07e-04 | 168 | 35 | 3 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 170 | 35 | 3 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 172 | 35 | 3 | 490745024730df6357f6c2b81d7a64e21557c0d5 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 174 | 35 | 3 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.45e-04 | 175 | 35 | 3 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.45e-04 | 175 | 35 | 3 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 179 | 35 | 3 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-04 | 180 | 35 | 3 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-04 | 180 | 35 | 3 | 97e0dcb7cfbba60a782824c5e23995058609fcd4 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-04 | 180 | 35 | 3 | b35a8c6169f4b548b912af005e92ae7c6596f376 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.81e-04 | 181 | 35 | 3 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.81e-04 | 181 | 35 | 3 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|Mesenchymal_cells / Lineage and Cell class | 3.81e-04 | 181 | 35 | 3 | 1cfb03eb03a37b036b4eeacec69c9b8163af1ee4 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-04 | 182 | 35 | 3 | d22ab50b135482915687c70e6dad29bfe2bb2c68 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-04 | 183 | 35 | 3 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 183 | 35 | 3 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 184 | 35 | 3 | fa5c3020e75fdde1363393dea97ebd99f1eae9ff | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 184 | 35 | 3 | 1d63cb75a89c5f3f3b9ebf7fce8cb0fd4a92b645 | |
| ToppCell | droplet-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-04 | 184 | 35 | 3 | ad520ab6bb776b5303df505b7e1afb22484f18a7 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 184 | 35 | 3 | 76caad53d55fff5acca27bf190a6de7b27437d9f | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-04 | 184 | 35 | 3 | 1fc1f0a3b4dbb085ebcc3960f67be24a108fe5b9 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-04 | 184 | 35 | 3 | 2467207aaea307873ab286f89cfc7668a227a694 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-04 | 185 | 35 | 3 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 185 | 35 | 3 | dec60254204014083ff3b4aec0cc75410950a486 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 185 | 35 | 3 | 201465dc0d7aa0336a36d37805cae1155a5adfe1 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 185 | 35 | 3 | 334f006c3ef33338ff8d649309d3f448733a3a99 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.13e-04 | 186 | 35 | 3 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-04 | 186 | 35 | 3 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-04 | 187 | 35 | 3 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | E12.5-Endothelial|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.19e-04 | 187 | 35 | 3 | b8ed57b3c39ffbf750cd08a3e03ec11dae43d00e | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.19e-04 | 187 | 35 | 3 | 63834420db930df91b62494c9d7aaa9a25bca530 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.19e-04 | 187 | 35 | 3 | 6cf7be5401b81a4eeb30840fb3733d61a24af539 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.19e-04 | 187 | 35 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 188 | 35 | 3 | da862ea3c74f42d0dbae38b09211a45c593d477e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-04 | 188 | 35 | 3 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-04 | 188 | 35 | 3 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 188 | 35 | 3 | b82a7667ef74a05e8bc744f6c090a7cc7b8efe32 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 188 | 35 | 3 | 19672d284fe89c9c3c7697514ca1f659329c34f4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-04 | 188 | 35 | 3 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.33e-04 | 189 | 35 | 3 | e830fa0ddc3dccfaf9e88e8c416ed6aab12e3e3f | |
| ToppCell | facs-Trachea-nan-18m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 189 | 35 | 3 | 5ced78f4b5c276b1bab24df807c00cf5ac8ed3d4 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.33e-04 | 189 | 35 | 3 | ecbe079606406f47d4fc97fe1670790dda8e10de | |
| ToppCell | facs-Trachea-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.33e-04 | 189 | 35 | 3 | f635f3f13bced3bcf796cf55723a2df851f973fe | |
| ToppCell | facs-Trachea-nan-18m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 189 | 35 | 3 | 2105d8b011b93a460237e00bc029efd7762dc8d5 | |
| ToppCell | facs-Trachea-nan-18m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 189 | 35 | 3 | 100eda87ac9c38dddcfa58408b057867a1738acb | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.33e-04 | 189 | 35 | 3 | 28b9e96a5206b7fdae9b17daf05c8f5d24b6c5ec | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-04 | 190 | 35 | 3 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-04 | 190 | 35 | 3 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 4.39e-04 | 190 | 35 | 3 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 4.39e-04 | 190 | 35 | 3 | ff083168d609957d00888f31b3488d6d56c902b4 | |
| ToppCell | facs-Lung-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.39e-04 | 190 | 35 | 3 | d55b3ad4d1ec172b042bc08127506c354f87f69d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.39e-04 | 190 | 35 | 3 | ac2eb1e51459d187095152e0cd41ae54c1025c6f | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 4.39e-04 | 190 | 35 | 3 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.39e-04 | 190 | 35 | 3 | 6010f16378f2d9cde37c7e7db6a7d9666edaddcc | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-04 | 190 | 35 | 3 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-04 | 191 | 35 | 3 | 79b399496bd7322a1d53c43378f48695fd09a5d9 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.46e-04 | 191 | 35 | 3 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | facs-Trachea-24m-Endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-04 | 191 | 35 | 3 | 9c6d5d045781c6506ae80e318427ef1e0d87f45c | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-04 | 191 | 35 | 3 | 1b1e943709d0c3283a980c7c965ef1f110506a29 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.46e-04 | 191 | 35 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.53e-04 | 192 | 35 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Heart|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | 67a7e07a11091120edbccf739836235c422ec9c6 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-04 | 192 | 35 | 3 | 1990dc8a81594018a5bf596be99d0b5f0af0f58f | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | 945153c41dde6e90d103206955e1707b54eb0665 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-04 | 192 | 35 | 3 | 845cc9c18b4436b07dd3ce7980052683937546d2 | |
| ToppCell | EC|World / Lineage and Cell class | 4.53e-04 | 192 | 35 | 3 | 478866dd5b0d6ff3a76d07a17c4b5989dd7a27bb | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | 6ab50579c63f31ca2cd41063a99b129f11c07510 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.53e-04 | 192 | 35 | 3 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-04 | 192 | 35 | 3 | c72a082c93a8825adbfef37f889ba3a7052f201b | |
| ToppCell | (4)_Endothelial_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.60e-04 | 193 | 35 | 3 | ae6ba13d4d9f2a700887cdda2790c32007b29ac8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.60e-04 | 193 | 35 | 3 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-04 | 193 | 35 | 3 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 193 | 35 | 3 | e164f6403a8b541ced08a6feec915d2e855036ea | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.60e-04 | 193 | 35 | 3 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | droplet-Lung-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.60e-04 | 193 | 35 | 3 | 95c9c63bddfed1a84393ccd3578cfe65bc0c1c05 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.60e-04 | 193 | 35 | 3 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 4.60e-04 | 193 | 35 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | facs-MAT-Fat-3m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 193 | 35 | 3 | b32533afeff1905e188becaa09079e9699722e4b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.60e-04 | 193 | 35 | 3 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.60e-04 | 193 | 35 | 3 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 193 | 35 | 3 | 2ff573ba2c74583ed1cb071a3bbc01bb71117e5f | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A | 4.54e-07 | 193 | 35 | 6 | 4289_UP | |
| Drug | Levothyroxine | 2.30e-06 | 2 | 35 | 2 | DB00451 | |
| Drug | Liothyronine | 2.30e-06 | 2 | 35 | 2 | DB00279 | |
| Drug | Liotrix | 2.30e-06 | 2 | 35 | 2 | DB01583 | |
| Drug | 3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid | 2.30e-06 | 2 | 35 | 2 | DB03176 | |
| Drug | KB 130015 | 2.30e-06 | 2 | 35 | 2 | ctd:C446946 | |
| Drug | Rafoxanide | 2.30e-06 | 2 | 35 | 2 | ctd:D011888 | |
| Drug | Dextrothyroxine | 6.88e-06 | 3 | 35 | 2 | DB00509 | |
| Drug | Bithionol | 6.88e-06 | 3 | 35 | 2 | ctd:D001735 | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | 1.13e-05 | 194 | 35 | 5 | 4249_DN | |
| Drug | Nitrofural [59-87-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 1.27e-05 | 199 | 35 | 5 | 3320_UP | |
| Drug | KB-141 | 1.37e-05 | 4 | 35 | 2 | CID009863447 | |
| Drug | 2,3',5,5'-tetrachlorobiphenyl | 2.29e-05 | 5 | 35 | 2 | CID000038878 | |
| Drug | 4-hydroxy-2,2',5,5'-tetrachlorobiphenyl | 2.29e-05 | 5 | 35 | 2 | CID000039971 | |
| Drug | diHPA | 2.29e-05 | 5 | 35 | 2 | CID000151819 | |
| Drug | closantel | 4.80e-05 | 7 | 35 | 2 | ctd:C023342 | |
| Drug | L-T3-PAL | 4.80e-05 | 7 | 35 | 2 | CID005487638 | |
| Drug | ioxynil | 6.39e-05 | 8 | 35 | 2 | ctd:C008161 | |
| Drug | N-bromoacetyl-T3 | 8.21e-05 | 9 | 35 | 2 | CID000122086 | |
| Drug | polyglyconate | 1.03e-04 | 10 | 35 | 2 | CID000123833 | |
| Drug | Thiazolidinediones | 1.03e-04 | 10 | 35 | 2 | ctd:D045162 | |
| Drug | ioxynil | 1.25e-04 | 11 | 35 | 2 | CID000015530 | |
| Drug | UVI 3003 | 1.25e-04 | 11 | 35 | 2 | ctd:C525131 | |
| Drug | dronedarone | 1.50e-04 | 12 | 35 | 2 | ctd:C118667 | |
| Drug | pazopanib | 1.50e-04 | 12 | 35 | 2 | ctd:C516667 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.70e-04 | 182 | 35 | 4 | 3887_DN | |
| Drug | Polybrominated Biphenyls | 1.77e-04 | 13 | 35 | 2 | ctd:D011075 | |
| Drug | desethylamiodarone | 1.77e-04 | 13 | 35 | 2 | ctd:C036116 | |
| Drug | tetrachlorodian | 2.07e-04 | 14 | 35 | 2 | ctd:C041181 | |
| Drug | 2,2',4,4'-tetrahydroxybenzophenone | 2.07e-04 | 14 | 35 | 2 | ctd:C035476 | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.18e-04 | 194 | 35 | 4 | 2106_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.18e-04 | 194 | 35 | 4 | 6507_UP | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 35 | 4 | 3735_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 35 | 4 | 6440_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; ssMCF7; HG-U133A | 2.22e-04 | 195 | 35 | 4 | 524_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 4718_DN | |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; HL60; HG-U133A | 2.26e-04 | 196 | 35 | 4 | 1414_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; HL60; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 1841_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 7276_UP | |
| Drug | Piroxicam [36322-90-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 2252_UP | |
| Drug | Nizatidine [76963-41-2]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3385_UP | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 7130_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3939_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 5242_UP | |
| Drug | Proguanil hydrochloride [637-32-1]; Up 200; 13.8uM; HL60; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 2944_UP | |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3554_UP | |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 7283_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 2197_UP | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; HL60; HG-U133A | 2.35e-04 | 198 | 35 | 4 | 1592_UP | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 6078_UP | |
| Drug | LY294002; Up 200; 10uM; PC3; HG-U133A | 2.35e-04 | 198 | 35 | 4 | 461_UP | |
| Drug | Reserpinic acid hydrochloride; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 6603_UP | |
| Drug | Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; HL60; HG-U133A | 2.35e-04 | 198 | 35 | 4 | 1426_DN | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 6248_UP | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.40e-04 | 199 | 35 | 4 | 5449_UP | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.44e-04 | 200 | 35 | 4 | 4797_DN | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A | 2.44e-04 | 200 | 35 | 4 | 4481_UP | |
| Drug | 1q4x | 2.72e-04 | 16 | 35 | 2 | CID000448011 | |
| Drug | Dicofol | 3.08e-04 | 17 | 35 | 2 | ctd:D004010 | |
| Drug | 1,1-bis(4-hydroxyphenyl)cyclohexane | 3.08e-04 | 17 | 35 | 2 | ctd:C517113 | |
| Drug | tetrachlorobisphenol A | 3.08e-04 | 17 | 35 | 2 | CID000006619 | |
| Drug | tribromodiphenyl ether 28 | 3.46e-04 | 18 | 35 | 2 | ctd:C533760 | |
| Drug | ulapualide A | 3.86e-04 | 19 | 35 | 2 | CID005289532 | |
| Drug | pyrrolizidine | 4.29e-04 | 20 | 35 | 2 | CID000012558 | |
| Disease | Anemia, Macrocytic | 1.29e-06 | 2 | 34 | 2 | C0002886 | |
| Disease | thyroid hormone resistance syndrome (implicated_via_orthology) | 3.86e-06 | 3 | 34 | 2 | DOID:11633 (implicated_via_orthology) | |
| Disease | Generalized Thyroid Hormone Resistance | 7.72e-06 | 4 | 34 | 2 | C4722330 | |
| Disease | Constipation | 2.70e-05 | 7 | 34 | 2 | C0009806 | |
| Disease | renal cell carcinoma (is_implicated_in) | 6.95e-05 | 69 | 34 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | breast cancer (implicated_via_orthology) | 3.80e-04 | 25 | 34 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | blood vanadium measurement | 5.49e-04 | 30 | 34 | 2 | EFO_0021533 | |
| Disease | diastolic blood pressure, systolic blood pressure | 9.59e-04 | 670 | 34 | 5 | EFO_0006335, EFO_0006336 | |
| Disease | Diaphragmatic Hernia | 1.03e-03 | 41 | 34 | 2 | C0019284 | |
| Disease | age at onset, alcohol dependence | 1.08e-03 | 42 | 34 | 2 | EFO_0004847, MONDO_0007079 | |
| Disease | left ventricular systolic function measurement | 1.18e-03 | 44 | 34 | 2 | EFO_0008206 | |
| Disease | mean reticulocyte volume | 2.09e-03 | 799 | 34 | 5 | EFO_0010701 | |
| Disease | aortic measurement | 3.00e-03 | 251 | 34 | 3 | EFO_0020865 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RDKMLCPSESMLTRS | 551 | O43310 | |
| TMLRRSARCLMEGKQ | 381 | A5YM72 | |
| MLDMLTDRCSTMCLL | 66 | O14735 | |
| VSCGRGLMELRFLCM | 906 | Q76LX8 | |
| GDRTRSMSCSDKMAR | 291 | Q9BUB4 | |
| KGSCCDMSVREALKM | 906 | O14917 | |
| SDCLGRRPVMLLCLM | 111 | Q14728 | |
| KRKTMLCLACGQSMR | 1316 | M0R2J8 | |
| RDKVQCILRMCSTIM | 1391 | Q14C86 | |
| LGLRRLSETMCTSCM | 326 | Q9Y2T5 | |
| RMTMSSLVERACCRD | 1116 | O95248 | |
| CMCGKERTSAMLTVR | 3696 | Q5VST9 | |
| MSMCRRVCRLPSKEE | 1891 | Q3L8U1 | |
| RARMMAAKLLGALCC | 676 | O14981 | |
| KCVTGMSCLMRKDVL | 206 | Q16739 | |
| RMGLTCISKDLMCSR | 81 | Q6UWE3 | |
| RLQCMMRAGTTLVEC | 141 | Q96NU7 | |
| RMKGVNLSCVRTCMV | 1266 | Q14689 | |
| KEMRRAFIRIMSCCK | 316 | P21453 | |
| CREMERLIKKLSMTC | 81 | Q13371 | |
| CSVTCGKGMRTRQRM | 626 | Q9HCB6 | |
| QSLSKRLKDMCRMCG | 1886 | Q9UHV7 | |
| RLKDMCRMCGISAAD | 1891 | Q9UHV7 | |
| LCPTIAESRRCKMTM | 186 | Q6UXX9 | |
| KATLCSMKGCMRALV | 516 | P25054 | |
| MNRICRMVLATCLGS | 11 | Q9NPF2 | |
| LLMCITRRMCGKKSG | 731 | O15394 | |
| GRCGALGKMSCLLRM | 446 | Q9Y2P5 | |
| MAEKRRGSPCSMLSL | 1 | O95935 | |
| KGCCMEIMSLRAAVR | 306 | P10828 | |
| MVSMSGCRRKCRKQV | 81 | Q9NY15 | |
| ASKGRMMRCLRCPVA | 811 | Q9BZ95 | |
| SRLMGRLASQCMALK | 1211 | O43149 | |
| LKGCCMEIMSLRAAV | 251 | P10827 | |
| LISSRLCTCTMLMLI | 356 | O15482 | |
| RQREMMKLTCERCSR | 106 | Q8WV99 |